Market Insight: TG Therapeutics Inc (TGTX)’s Notable Drop, Closing at 35.63

For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.

In the latest session, TG Therapeutics Inc (NASDAQ: TGTX) closed at $35.63 down -1.06% from its previous closing price of $36.01. In other words, the price has decreased by -$1.06 from its previous closing price. On the day, 1.3 million shares were traded.

Ratios:

For a deeper understanding of TG Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.04 and its Current Ratio is at 4.02. In the meantime, Its Debt-to-Equity ratio is 1.07 whereas as Long-Term Debt/Eq ratio is at 1.06.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, TD Cowen on October 29, 2024, initiated with a Buy rating and assigned the stock a target price of $50.

On August 02, 2023, Goldman Upgraded its rating to Neutral which previously was Sell and also lowered its target price recommendation from $16 to $12.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 13 ’25 when Echelard Yann sold 10,000 shares for $36.94 per share. The transaction valued at 369,400 led to the insider holds 228,816 shares of the business.

Echelard Yann bought 10,000 shares of TGTX for $369,348 on Jun 13 ’25. On Jan 03 ’25, another insider, Power Sean A, who serves as the CFO of the company, sold 11,337 shares for $30.29 each. As a result, the insider received 343,443 and left with 670,632 shares of the company.

Valuation Measures:

As of this moment, TG’s Price-to-Earnings (P/E) ratio for their current fiscal year is 146.02, and their Forward P/E ratio for the next fiscal year is 20.34. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.95. For the stock, the TTM Price-to-Sale (P/S) ratio is 14.64 while its Price-to-Book (P/B) ratio in mrq is 23.75.

Stock Price History:

Over the past 52 weeks, TGTX has reached a high of $46.48, while it has fallen to a 52-week low of $16.21. The 50-Day Moving Average of the stock is -4.39%, while the 200-Day Moving Average is calculated to be 11.74%.

Shares Statistics:

A total of 158.17M shares are outstanding, with a floating share count of 142.95M. Insiders hold about 9.96% of the company’s shares, while institutions hold 62.70% stake in the company.

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.